ANI Pharmaceuticals, Inc. (ANIP)
75.54
-0.99
(-1.29%)
USD |
NASDAQ |
Mar 05, 14:57
ANI Pharmaceuticals Cash from Investing (TTM) : -34.32M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| CorMedix, Inc. | -312.03M |
| Castle Biosciences, Inc. | -60.37M |
| Arcutis Biotherapeutics, Inc. | -30.25M |
| Allogene Therapeutics, Inc. | 116.88M |
| Amicus Therapeutics, Inc. | -46.43M |